Ability of serum alkaline phosphatase (ALP) changes to complement PSA changes and predict survival in men with metastatic castration-resistant prostate cancer (mCRPC) receiving docetaxel and prednisone (DP).

被引：0
|
作者：
Fleming, M. T.
Pond, G. R.
Armstrong, A. J.
Wood, B. A.
Brookes, M.
Leopold, L. H.
Matveev, V. B.
Burke, J. M.
Caton, J. R.
Sonpavde, G.
机构：
[1] US Oncol Res, The Woodlands, TX USA
[2] Virginia Oncol Associates, Hampton, VA USA
[3] McMaster Univ, Hamilton, ON, Canada
[4] Duke Canc Inst, Durham, NC USA
[5] Ascenta Therapeut, Malvern, PA USA
[6] Russian Acad Med Sci, NN Blokhin Canc Res Ctr, Moscow, Russia
[7] Rocky Mt Canc Ctr, Aurora, CO USA
[8] Willamette Valley Canc Ctr, Eugene, OR USA
[9] Baylor Coll Med US Oncol Res, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e15019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15019
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy
    Sonpavde, Guru
    Pond, Gregory R.
    Berry, William R.
    de Wit, Ronald
    Armstrong, Andrew J.
    Eisenberger, Mario A.
    Tannock, Ian F.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (05) : 607 - 613
  • [2] Evaluating the value of continuing docetaxel and prednisone (DP) beyond 10 cycles in men with metastatic castration-resistant prostate cancer (mCRPC).
    Pond, G. R.
    Armstrong, A. J.
    Wood, B. A.
    Brookes, M.
    Leopold, L. H.
    Berry, W. R.
    De Wit, R.
    Eisenberger, M. A.
    Tannock, I.
    Sonpavde, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Use of changes in serum alkaline phosphatase to predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy: A retrospective analysis of the TAX327 trial
    Pond, G. R.
    Sonpavde, G.
    Berry, W. R.
    De Wit, R.
    Armstrong, A. J.
    Eisenberger, M. A.
    Tannock, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Efficacy of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer (mCRPC) exposed to prior ketoconazole (KC).
    Pond, Gregory Russell
    Armstrong, Andrew J.
    Wood, Brian A.
    Leopold, Lance Howard
    Galsky, Matt D.
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [5] Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel
    Sonpavde, Guru
    Pond, Gregory R.
    Templeton, Arnoud J.
    Fandi, Abderrahim
    Tombal, Bertrand
    Rosenthal, Mark
    Armstrong, Andrew J.
    Petrylak, Daniel P.
    EUROPEAN UROLOGY, 2016, 69 (06) : 980 - 983
  • [6] The influence of prednisone on the efficacy of docetaxel in men with metastatic castration-resistant prostate cancer
    B A Teply
    B Luber
    S R Denmeade
    E S Antonarakis
    Prostate Cancer and Prostatic Diseases, 2016, 19 : 72 - 78
  • [7] The influence of prednisone on the efficacy of docetaxel in men with metastatic castration-resistant prostate cancer
    Teply, B. A.
    Luber, B.
    Denmeade, S. R.
    Antonarakis, E. S.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2016, 19 (01) : 72 - 78
  • [8] Validation of correlation of RECIST changes with survival in metastatic castration-resistant prostate cancer (mCRPC).
    Pond, Gregory Russell
    Templeton, Arnoud J.
    Petrylak, Daniel Peter
    Fandi, Abderrahim
    Tombal, Bertrand F.
    Rosenthal, Mark
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] The effect of therapeutic anticoagulation on overall survival (OS) in men receiving docetaxel chemotherapy for metastatic castration-resistant prostate cancer (mCRPC)
    Pratz, Caroline F.
    Brodsky, Robert A.
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [10] Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC).
    Maughan, Benjamin Louis
    Suzman, Daniel L.
    Nadal, Rosa
    Bassi, Sunakshi
    Schweizer, Michael Thomas
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
12345